Achaogen (AKAO)- Blake Wise, COO, sold 3,632 shares at $4.30. The total value of the transaction was $15,620. Wise still owns 45,118 shares of AKAO. Zeryn Sarpangal, VP, HR and Corporate Affairs, sold 1,069 shares at $4.30. The total value of the transaction was $4,597. Sarpangal still owns 17,742 shares of AKAO.
BioMarin Pharmaceuticals (BMRN)- Jeffrey R. Ajer, EVP, Chief Commercial Officer, sold 18,467 shares at $95.61. The total value of the transaction was $1.76 million. Ajer still owns 41,342 shares of BMRN.
Synergy Pharmaceuticals (SGYP)- Paulson & Co. Inc., a 10% owner, sold 54,300 shares in two separate transactions. Paulson & Co. sold 33,600 shares at $5.75; and 20,700 shares at $5.60. Paulson & Co. still owns 24,228,655 shares of SGYP.
Atara Biotherapeutics (ATRA)- Isaac E. Ciechanover, CEO, sold 12,000 shares in three separate transactions. Ciechanover sold 7,200 shares at $20.50; 300 shares at $21.82; and 4,500 shares $21.40. Ciechanover still owns 406,878 shares of ATRA.
Kite Pharma (KITE)- Cynthia M. Butitta, COO, sold 10,000 shares at $54.13. The total value of the transaction was $541,300. Butitta still owns 95,477 shares of KITE.